Status:
COMPLETED
RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population
Lead Sponsor:
Medtronic Vascular
Collaborating Sponsors:
Medtronic Cardiac Rhythm and Heart Failure
Conditions:
Coronary Artery Disease
Cardiovascular Diseases
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of the RESOLUTE international registry is to document the safety and overall clinical performance of the Resolute Zotarolimus-Eluting Coronary Stent System in a 'real-world' pati...
Detailed Description
As part of the broader clinical program of the Resolute stent, the RESOLUTE International registry will expand the experience and understanding of the device performance in a 'real-world' setting. The...
Eligibility Criteria
Inclusion
- Minimum legal age (18)
- Acceptable candidate for treatment with a drug-eluting stent in accordance with applicable guidelines
- Patient has consented to participate and authorized in writing the collection and release of medical information
- Elective use of the Endeavor Resolute stent
Exclusion
- Pregnancy
- High probability of non-adherence to the follow-up requirements (due to social, psychological or medical reasons)
- Currently participating in another trial preventing routine hospital treatment
- Previous enrollment in the RESOLUTE International registry
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
2349 Patients enrolled
Trial Details
Trial ID
NCT00752128
Start Date
August 1 2008
End Date
December 1 2012
Last Update
April 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heart Center Bad Krozingen
Bad Krozingen, Germany